A REVIEW OF ABBV-744 IN COMBINATION WITH IMMUNOTHERAPY

In Section A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to recognize Protected dosing routine. Further participants will be enrolled at the discovered monotherapy dosign regimen. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 is going to be provided as "add-on" therapy. In Section C, particip